drugset / Trial / NCT00088010

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

NCT00088010

Phase 3 Completed 9369 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to study: * Effects of arzoxifene on bone fractures and bone mass. * Effects of arzoxifene on getting breast cancer. * Effects of arzoxifene on certain types of cardiovascular events, such as heart attack and stroke. * Effects of arzoxifene that changes the amount of certain substances in the blood that are related to osteoporosis and cardiovascular health. * Effects of arzoxifene on the uterus. * The safety of arzoxifene and any side effects.

Timeline

Start
2004-06
Primary completion
2009-06
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject arzoxifene Other / unclassified 20 mg Oral